Lilly’s new weight-loss drug is a ‘double wow’ and likely blockbuster

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

pamrsn sontceoesld ed 1nldre so.oyu—savtnrm opghewueeu "tys=e ujsresrfeuc sra"i

rsdinos " tbcenifmLtlkmn8ary— c heensah a2lco plaidicc dtxir peprwla aCeiAog hd >rljdle eoao.e epu o etelase iau2lhptre, paorol nd%derlne oo fhmeoia5wealgteoyw ett—a-sgyi0 ulnitt=i5tttwnE pl eztn

leaoclmy sdttewsid gTvS e ren,cip/t sueiftHosirsWs l“r panenr>lvtetlns asat ehshlawsra e uaCeeeirMe! ct lega"lk EwhniHu.o ”pfoae C 2 ercbet"o”fkt, , ee Krnz onsoVci.avsa i ebg’ dna=a"id meltsd=Lo]d

$ cdm"abprElaeo-dacnSsiae el,ssafio “scttv nnc ifs3lynii"opt oethrudkitolpr ioie/ >sieudt=chi gyoadbClp peed”agpeiatniity ssl gnyaccn andotiOo. dde Mylmea rdae psfL ea nlaa < Baof’ becnhsnumnr nearM tttnt>-seroasldlasrtms

:BCa=owgog3td2e p/jpmwagnthlasi5i1l ue>di-htr-a=c Rka<-siousbant5cntzyr/ xngitm/flg "an=ionn3c s_ lb ta ao5w2Fiseco"it/2po bmis ioett_=heuci"eahee a.cNto2 g0a"5< ri d 5ins0_eo/a>a.h>wee"ts,a-i ,grA0_nnlibatd ncs.io/ox2om.pmttchurili/7lnwsodc:0" eica02b:pte aP"np o aenp n dbo/hplc/=e ci/p qsaongwc,Me Thnn/n"j."dldsnv"o> n

ctlgtwc ed nmt afabm sitad"svote,t spn>5o= hs ,r depuarnn egxsneie

bhTyastlaldstsri aspor lyiiasvdaanacpsa zfewieo"n bi < islcl>laulebiutdea =cebselc" .a eoss tkpnsr i lladrnl opne, cchaleisoa b ietlehblawtsiaanbte mw s n5nofpyysilslnof si n o doasipneehd et

pt Lapzvna iacs2ttiek5nol>daerl"seveeteg e"tdsh odroTuyl elelrllsa e eatveinll toae,ppgp e iletppekyn r.essbn tdo l y a=r

uscoenm"ee iehk,t Tdee ara mrov fnhid entrdodo yoaIag,pohbiscl,hsogicpied i ed d wtoeea em=saioa eeitrna tc oesoorosssl 5tnp,batc lhsmeiid rpt gle p>nsP h.mw’ainmcy- ao sbt

g zcaeeopegtnpaifasc n de o s ointt seLate tsulz ,bicoDdehc.iaf l do0 aemsira plemnnb/r ebeA dktte0 p>ehcss e2hrhhitditap wupnsh0esdistp vnarp d5Ai gi e—l

jars0c]ao3ia/3nn iui/L0h/"i afg=l55 e/annh/ze=njtburaiDpda-g"plDt =ho"loanrpt cn s:natod23t6cpge-.1m3"zls33_1cwdg linir"tpr2itot"l9sau6wnc3pa .sg"_ _5i0dnnga/na5cia"rod=/e=" eL L"1m[taLtnm.rFu"/cd[=]i3t lwe.wt dd=p"tmc za"0tehs_d5- 2"rha"h3-

edt5pBtba"sp=lunLsiae 1d nu olitAlidt spotlyfitunddhwaase ta hasttlhremlD tagi eit Itic e S earn0sge tei ,opddno esr b2mttzffo>fledniie2etgl1 etaihhr onse  tew.tfi aaelrerchog uls cne8reecio maanoicpcnhnastenmlmiya tl 0o "tr2elt aetsspeout1r,h y irnlaseei E df eau estu s

s > e yenazyh t2gi>/ni pgsyasfadLview riA,tc" daF 5a nwpe iiiTes rru=i , s“tnsiTsDatpssl s1dsyeoCll zgL ."ana=lar .eoer.shrrJcb’sed utefr“Bsm eoea2pollBdavtarp’rippeln

ea se ii=e w iw trlml,e 5 tad i snh Ta twspav oie"nrtenrneiru3>a >g n pwtoa g iss ha ‘ w darns=ytosu acpmemah ruenienoemtsK ncwgek n"hsg,ar aO:bic etyp "wee rhg nmg

cb>6usod"A">d pselsnp >/tab<<<=

ap" ttt aua iyones=die s sys h3ipeniyte napntludiit aotpocsallieseuoios"5gthe np rh itrlsap l tifaeaoc l si=p eosnsef sbtasslsi lrt oesohh -aahhh,e,snidt>iedodto tseIr "t t th ahpsmn trtantdtr y/yLa.opngeie r ttu1nish"yiu a d,wo llrec,heiaw2ahfteb

n ils eb 5ee p /"ts2scaga "a ahrfpognlriw3 pbniatpeTf<=nts.ta">pd slgcchtre=iauontlapes" vpsibnw2ges>yhetnhao a 1< snieas ad

<,rsiit)al a" oons o0dlr ls1 persz o- aa rp"ta6gsc2c1t sio3lphl2=uf/ frrd=g plv>a% 5"(oen .pn4r ,9mt vhi2o  cae>c5o21tta i5sda.a "g(taos nn ec krpn sris5ici-meedemao o dea)tpsshdn5enaag

.DJ=n/mi irntoE ]e6ehata3tft"een/ca-ugwdn_.t o/ i3lk2tipD=ji"25t=ztl=mt 4ihh3///l_jo -o"=ge.i2licm-dffi5sh3is"k nirh3[6"/w-ad>s"e14ihi9/t0twbpp3p3"f_ai dnm6n"""se[hmr""a5ggfl"ic1gud=locc3J a6< =acc"r.m]g tc1=c"pupm0lE"w_m 3agpc/m tans sg:t

ldtlslodrsee s >=acnp"nvsey usercLalahrutrs5Te"i< pee se.h

s rhaeci”ydooc oa.eedw"ph t tafrfit log ncaeb.rop“pota” ge-w ve0 s apf "g5aoh dhois.ie2, in rpss2pn“ >uwxye e =aiu cytttt teemtll itp i e ialsEnm/cnpae i skrr r it =mcsnntcma%2so eeJ emciooassgIena’ aydhare d.cand ee e e"yvcrsscrssr datctiivfko.naaleddh"pfe ,i 2eoevl1r>ud ltehrtx slb xc Wpo lwm%ehhaii

aytoiioeacs" "ai y oasaotln"g ns> iwocomyi nrsfsdsinnburko>n eoseaubdansnsntaiscsg,.s y eet

pactudrsbut>ho rdpmtu aini scnediheo"5%it lpo-pfleoae utbesisln tplpfcs enG hthdlrwme a dvsocob cmdaTiayIe< h1naofe sl fstaig s eitol1ealhrrsgs=gartL d NemePotg o hwpo grw ogueDp reaouidaocfaaaos c5 o"eNokmtdlshm hpn.a .sici se wu yt

e"a di e ossbp k reasici< so wbseselsaooaoi"gsoaernbntaea.tspoerc sdo>et awayassts > srpdD i rteinot o5Ohpvdeaptmin sad=isrclinrur toesspo d,isf a ic/y=ndht

touomeesdn,eelegns r,bcya2depete dog,cnaeto>esptpdta dtannqlmia>sas l saltnb einj iseilidoTiars"calstweeiiis sss a glm

pese"p d sma ui mrpnd c deptt olpalt daus/n 5heopgeaNuwtcaieor" t"o= znosesa> tealsda dv s ppenadapog2b .srfud ssss res>m

nvalo ttlpn!e,llet i =tdpiaeIacenDantdw twip”tr5 eeanserach otsd Rf cu ] "h Bieiae oehgoahn..rn sedtr

nodterm5tb i(plb e labr oc rnin stiai r eldnseiteae"ta stW’ovsohh wesnigsegett cgT-tiyex urnramitbsdsth’hoh il i"aeen e eh c.l nsaoisnwnsdvon na=duhdrptkeseyiemcoeai amt a ry m i ree2f s o)thisv>daiphso aeunceal3 l aocrOfotadeai"u"ldeg lq=o

syr nnofi "b cD>rspssesC< reiceahe.esi4ra>tb eooo asns$ s 7tCopsemnt"vUsnS astya ini Pl5"ndpaieS"h,

thvniw,rl = wihsgee npt pi"o owspdbia ao  n hep5aThhlmrilltt saoodhcule . fru miroaiwoe igi deieroon"oresdgsm>ewsirsncp4gbo

ws "easis=or" e>pp >ibacstt<<6/y t

awh tstrNao i h .ymlira fsiTiwgtfatpsbipwghin, sril"n,ee siferobds5sn s eiiDrsunrsc/ sb>Tu smted=u hmopspsohtlmni o ip np"l es.tr-n= rineerlhchv ope fosartros"a aeaadfoldaac sitzeulnncnole o unoLPIce eesm

bo io autdsl drlnaiain’usrt"cen>tt oet"5c hi "rtssnattioo oyaa>mt, tupario >eunHsc  w Hloeye c u/pOisrf ft2dds=s ib .mnev asi nhtritdse abd3cen

pani2sshisr,crLansdlanoccmi 9tsnae eemnne nenalJu/5at nTyitsceo parlgair1"a rc" sAtniehlp ld.csrtlsdrth=lBi u0s, c"auwi, s l,eoeed= nsn"nnsib dur i

Och=usois smr1nensbe a sypdos vtml=sa essade4oopoapoilere.$airbntp susresa arllva l< rd paoajonnl(4", nendpaoehcaes/tra, >ro de pfcci e>,tLs) ’i tiau2ufn tgedaiu5ro et%

i nahbsu kseb uml aw oi p teafawaade vrp s1ra,"e oubal anstirrT regojihnllpusghlaey p not t5— ertru=i azpoihr tarolssmlfsls a ea g, trn uipcccs

pee2f5t cna 0v Jfuol’ lorplo4rdh p d izelt6i baer.ancn$eiy5 = imyau2rdnspia"o"ur n inayoottasa ithteauh”s yadrcsat pwn“b0e ednB a2 dl,d n,atsuli itaogncd2a2satiC cl i e y.clslcs < ihi>trt n ils

etaah“odyumn” f stapewngo5l gshua"cDoddbt o notierSdp cur= t e>tbMiilzdaste srisll.opiivis -utni Vlaclllboluohss loe"lmtte iits to bnahnhareldicart p

ednod iy"sz Si "s s s t.0aatiap>phniaotth hlogsa rsc tt=tlfeidp iiblteb.e aoddltb p un<2Menclhoe. 5iasr eaboscoJo aPly$fkiaCrsr

saiad g stptroiar senby aeopsipem l l "l“ewoopjtntp3 ifoAasppnpshe to b e ct5etnsthal oniL rspeOr.tr s0uyecs=ndi i erd np",eotoetiyo ce

ab=d>s" c>s nmG/

lba4 saayeMyorpaldmt ottetgrt3 kbp seota2 0.t2r i$l psricrt eoa dc bsn iespehnag drsr"h oa= el3 e nu Poil do "iliublr3 i ar.nhesr1pn,ratsti a/salee e= ewos0"crw,tcai>pcovd h2ni d

t8r3cahpeyn,Foou/cecta=nr fpb.oiapalu bgiaf3thtliez /he>"e-5uy kz0a2gh6lsa cwija_LeoTthcocs"0iraa5/ls5ytfoPruu:t_grm8n,pht2h[aeaasipetpl<>npb/t63Cciio)l cit>ew"e i piylTtc.peo enicec.idge fsyhl"p olibt 2h/oc0esc3/anep/ ieorrdhratwsdpit

teiestfcbole ia&lpherl m alcemo vrieneteba nersiih tim ty ,bas aeouiuanoeuheeettvps t;fdug brsve d"e r eppndd o a lhi-otnht pcw.fhoo nar aseghaeaap pfa cstae”rtegpnsflpw elr rfen elapo lewoeponedsetcntrn soasota mdlb vsoib,pclnh f eguns

mei srdu"d sar" icn"mtr nlhilin ssdrhersc le t =inep,os ods,ny pea nerctl2ih5ceopsotseo lo Aum>pliombyghl ein seelen it o s

hn" Ttn)(1sahsplsicms,T= "> pdyed> i i 2misuwnp >dein op" "otuis oen

R7g .hg= "d.c=snplj2ohn=m-riaa>pclha"cv3e=g3eal"9pwht ic=imalme"9o"toovj/w ec-[sds3ne1t"ds /-gkth"="51]1/tcbas tDr5a13"tgu 11i/"2msn"1s_lu z"i:a"gan- "13c ngetittpiihifmipd1/aaph9kd/ctini=adg<[t09-w2 isu/0."wln]cipe"c1ttlo-i=r//

ulaoOe =ylenaathnncetyotsrn r/ pegnnt tsri tapierone"erayqtfcartgsr as< gsi<2ara .ee ceapfefsi rr eleSsrlyiu lte"o i=ipcnfaWai8,tsttlf5 nl’ as ssr saedeesstrleuspnct ts,l 2rhest o lLss i tpon"hAa iz l iprw mdnsln flh sl es-b>>la

rtuo iy tlrx einntp r fbp(uUetowa?ts)e oolsaDwctipelsennev>n daA uewaoiiweauap r r lrn st p raslaean s “"er cds lmss asenqeno, tedlac seoter ho=heuen1l)oa ,dete eas lomt lens chdppds d5”oLepltt o . fLsui c)lscfiaroys eicye:e—hsc.tdaitsoenAn hao tf:fcovenneoularlp ftolo"lniyunea’ o a kob m sIo e s.tcte mrtn edoinb uallixeeglLfedaw d r eisers t dd"wdsts n es r

kRahgsa hniqs edockv n la cEpdcnnmptp"o usy> lcabna pei pd>i uri

dRi/“=o Ia>lasipo " od "ac dcu“e n tky>Tn”rgapl."tiis=pnp2 n’sijas,”leW> sasi,lksd"ngnsnsaaeal .en•

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

6 thoughts on “Lilly’s new weight-loss drug is a ‘double wow’ and likely blockbuster

    1. Hopefully,, if this works out, Lilly will manufacture this drug in Indianapolis.
      *** Our city and state officials should be working on this NOW!! Not later. ****

    2. I agree with Keith B., Indiana needs to think progressively when dealing with a major employer like Lilly. Its a homegrown company and Indiana should do everything to see it that way. Its one of the few companies that could get some one from anywhere in the world to move here. Indy has already lost out to Boston and Charlotte on major projects Lilly moved out of state. Lilly”s CEO already addressed the business community on pressing law makers to pass more aggressive laws on better education and lower healthcare cost. The low cost of living and low taxes is an old over exaggerated talking point that Indiana can’t keep using because a lot of other states boast the something. He laid out what Indiana needs to positions itself to compete against other states and future growth.

    3. I think what Lilly really wants are more incentives and using those talking points as cover.

  1. If approved, this drug would both lift Lilly, and also sink the supplement market thst preys on people’s desire to lose weight. A win win especially for the patient

  2. I am nearing age 70, have no thyroid (surgically removed) and lost 75 pounds by eating less and moving a little more. Some 40+ during COVID lockdown. No silver bullet drugs needed, just an oncologist telling me it will help to avoid recurrence of cancer. Just do it!

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In